Jubilant Pharmova Limited has informed the Exchange about General Updates
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jubilant Pharmova has updated that it, rather than its wholly-owned subsidiary Jubilant Biosys, will directly invest up to 14.53% in Isharays Energy Two Private Limited (a SunSource Energy subsidiary) for captive renewable power. The renewable energy available is sufficient only for the company's Greater Noida facility, where Jubilant Pharmova is the primary user. The total cash investment is small at approximately Rs. 3.094 crore for 30.94 lakh equity shares at face value of Rs. 10 each. The arrangement gives the company access to up to 5.89 MW of solar power through a captive generating plant to reduce energy costs and carbon footprint. Expected completion is around November 20, 2025.
This is a minor internal restructuring with negligible financial impact — a small Rs. 3 crore investment for green energy cost savings at one facility. No material change in business direction, earnings outlook, or shareholder value is implied.